Thrombin cleaves IL-33 and modulates IL-33-activated allergic lung inflammation.
Yuying HuangXuezhen LiLin ZhuChunrong HuangWen ChenZhiyang LingSongLing ZhuXintong FengChunyan YiWangpeng GuChenghua YanJing WangLiyan MaXiao SuRanran DaiGuochao ShiBing SunYaguang ZhangPublished in: Allergy (2022)
The data suggested that thrombin inhibitors administration could be effective in treating lung inflammation by regulating ILC2s via IL-33 maturation, indicating that targeting thrombin is a potential way to treat allergic diseases.